Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
PAVM
PAVM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest PAVM ETF News Today | Earnings, Events & Price Alerts
PAVM News
PAVmed Secures $30 Million in Series D Preferred Stock Offering
Feb 04 2026
PRnewswire
PAVmed Subsidiary Secures VA Contract for EsoGuard Test, Expanding Access to Over 9 Million Veterans
Jan 22 2026
Benzinga
Lucid Diagnostics Secures VA Contract for EsoGuard, Boosting PAVmed Stock by 291%
Jan 21 2026
Benzinga
PAVmed Subsidiary Wins VA Contract for Esophageal Precancer Testing, Shares Surge 250%
Jan 21 2026
stocktwits
Netflix, Inc. (NFLX) Reports Q4 Earnings Beat but Issues Lower Q1 Guidance, Shares Down 3%
Jan 21 2026
Benzinga
Lucid Diagnostics (LUCD) Secures VA Contract for EsoGuard Esophageal DNA Test at Medicare Pricing
Jan 21 2026
seekingalpha
Lucid Diagnostics Secures VA Contract for EsoGuard Test, Expanding Access to 9 Million Veterans
Jan 21 2026
Newsfilter
PAVmed Executes 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing
Dec 30 2025
PRnewswire
PAVmed Executes 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing
Dec 30 2025
Newsfilter
Lucid Diagnostics Reports 95% Success Rate in 11,991 EsoGuard Tests for Esophageal Cancer Screening
Dec 09 2025
Newsfilter
Biotech Stocks Surge in After-Hours Trading with Gains from BioAtla, Entero, and Sonnet
Dec 01 2025
NASDAQ.COM
Lucid Diagnostics Recognized as a Top-Ranking Honoree in GenomeWeb's 2025 Best Places to Work
Nov 20 2025
Newsfilter
Lucid Diagnostics to Join Canaccord Genuity's MedTech, Diagnostics, and Digital Health & Services Forum
Nov 13 2025
Newsfilter
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Nov 12 2025
PRnewswire
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025
Oct 30 2025
PRnewswire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Oct 29 2025
PRnewswire
Show More News
